These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 6409520

  • 1. In vitro activity of pristinamycin against methicillin-resistant Staphylococcus aureus.
    Mutton KJ, Andrew JH.
    Chemotherapy; 1983; 29(3):218-24. PubMed ID: 6409520
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. In vitro activity of N-formimidoyl thienamycin and other beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus.
    Thompson RL, Fisher KA, Wenzel RP.
    Antimicrob Agents Chemother; 1982 Feb; 21(2):341-3. PubMed ID: 6951505
    [Abstract] [Full Text] [Related]

  • 4. Interactions between methicillin and vancomycin in methicillin-resistant Staphylococcus aureus strains displaying different phenotypes of vancomycin susceptibility.
    Howe RA, Wootton M, Bennett PM, MacGowan AP, Walsh TR.
    J Clin Microbiol; 1999 Sep; 37(9):3068-71. PubMed ID: 10449511
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In-vitro activity of methicillin against clinical isolates of Staphylococcus aureus.
    Frimodt-Møller N, Hartzen SH, Espersen F.
    J Antimicrob Chemother; 1985 Feb; 15(2):173-80. PubMed ID: 3156838
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [The combined effect of methicillin and teicoplanin against Staphylococcus aureus strains investigated in vitro].
    Młynarczyk A, Młynarczyk G, Luczak M.
    Med Dosw Mikrobiol; 2005 Feb; 57(1):1-6. PubMed ID: 16130290
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Newer agents against methicillin and/or gentamicin-resistant and -susceptible staphylococci.
    Chandrasekar PH, Sluchak JA.
    Chemotherapy; 1989 Feb; 35(5):333-7. PubMed ID: 2551600
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In-vitro activity of RP 59500, a new semisynthetic injectable pristinamycin against staphylococci.
    von Eiff C, Peters G.
    Zentralbl Bakteriol; 1996 Apr; 283(4):497-501. PubMed ID: 8737948
    [Abstract] [Full Text] [Related]

  • 15. The activity of ofloxacin against methicillin-resistant Staphylococcus aureus.
    Mraović M, Canić-Radojlović M.
    Infection; 1986 Apr; 14 Suppl 4():S231-2. PubMed ID: 3469151
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. In-vitro activity of paldimycin against methicillin-resistant and susceptible isolates of Staphylococcus aureus and S. epidermidis.
    Pfaller MA, Bale M, Barrett M.
    J Antimicrob Chemother; 1987 Aug; 20(2):286-8. PubMed ID: 3667485
    [No Abstract] [Full Text] [Related]

  • 18. Erythromycin-induced resistance to clindamycin in Staphylococcus aureus.
    Marr JK, Lim AT, Yamamoto LG.
    Hawaii Med J; 2005 Jan; 64(1):6-8. PubMed ID: 15751751
    [Abstract] [Full Text] [Related]

  • 19. Comparative in vitro activity of quinupristin/dalfopristin and seven other antimicrobials against methicillin-susceptible and methicillin-resistant nosocomial Staphylococcus aureus bloodstream isolates.
    Nikolaidis P, Metallidis S, Katikaridou E, Chatzidimitriou M, Kollaras P, Tsona A, Koumentaki E, Tourkantonis A.
    J Chemother; 2002 Dec; 14(6):544-6. PubMed ID: 12583543
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.